Editorial
February 15, 2019
To Dose or Not to Dose?
Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.January 18, 2019
Brain Changes Signal Nascent Alzheimer’s
December 18, 2018
Making Its Mark on Crohn’s Disease
November 20, 2018
Reducing Dementia Risk
October 16, 2018
Diabetes Mainstay Might Defeat Colitis
September 14, 2018
Genomics Targets Aggressive Breast Cancer
August 17, 2018
Hair-Raising Research
July 12, 2018
In-Pharmacy Asthma Testing Next?
June 15, 2018
The Melanoma Menace
May 18, 2018
Specialty Pharmacy Serving Pediatric Patients
April 13, 2018
Defending Flu Vaccines
March 16, 2018
A Many-Pronged Approach
February 16, 2018
Heart Attack Harbinger?
Continuing Education
$6.97 Per CE Exam or $59 for 12 Lessons
-
Cardiology • February 2021 • 2.00 Credits
Assessing Aspirin for Primary CVD Prevention
-
Gastrointestinal Diseases • January 2021 • 2.00 Credits
A Pharmacist's Review of Nausea and Vomiting
-
Neurology, Cardiology • December 2020 • 2.00 Credits
Preventive Treatment for Patients With Migraine and Cardiovascular Disease
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.